Rapal, Jeffrey C.
HRN: 27-08-05 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/03/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/03/2025
05/10/2025
IV
1.5g
Q8h
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes